Vogt SB

Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland.

8 papers · ORCID

ArticleDMT

Dose-dependent pharmacokinetics and acute effects of intravenous bolus N,N-dimethyltryptamine: double-blind, randomized versus open-label dose-escalation administration study in healthy participants.

Erne L, Mueller L, Straumann I +7

Europe PMC2026
ArticlePsilocybin

The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.

Stocker K, Hartmann M, Schmid Y +10

Europe PMC2026
ArticleKetamine

Development and Validation of a Rapid LC-MS/MS Method for Plasma Analysis of Ketamine, Norketamine, Dehydronorketamine, and Hydroxynorketamine.

Thomann J, Kraus S, Erne L +3

Europe PMC2025
ArticlePsilocybin

Clinical pharmacology.

Vogt SB, Liechti ME

Europe PMC2025
ArticlePsilocybin

Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.

Ley L, Liechti ME, Becker AM +6

Europe PMC2025
ArticleDMT

Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants.

Erne L, Vogt SB, Müller L +9

Europe PMC2025
ArticleDMT

Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants.

Vogt SB, Ley L, Erne L +12

Europe PMC2023
ArticleDMT

Liquid chromatography-tandem mass spectrometry method for the bioanalysis of N,N-dimethyltryptamine (DMT) and its metabolites DMT-N-oxide and indole-3-acetic acid in human plasma.

Luethi D, Kolaczynska KE, Vogt SB +4

Europe PMC2022